Targeting the MEK1/2 pathway to combat Staphylococcus aureus infection and inflammation in cystic fibrosis is a research paper published in mBio (2025). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Cystic Fibrosis Foundation
Grant: LONG19F5-CI
Cystic Fibrosis Foundation
Grant: LONG21R3
HHS | National Institutes of Health
Grant: T32TR004543
Cystic Fibrosis Foundation
Grant: MCCOY19R0
NCATS NIH HHS
Grant: UL1 TR002733
NCI NIH HHS
Grant: P30 CA016058
NIAID NIH HHS
Grant: R01 AI186380
National Institutes of Health
Grant: 5T32TR004543-02
CTSA Predoctoral T32 at the Ohio State University
National Institutes of Health
Grant: 5UL1TR002733-02
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
FWCI
0.93
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals